Human blood contains both the uncleaved precursor of anti-Mullerian hormone and a complex of the NH2- and COOH-terminal peptides.

@article{Pankhurst2013HumanBC,
  title={Human blood contains both the uncleaved precursor of anti-Mullerian hormone and a complex of the NH2- and COOH-terminal peptides.},
  author={Michael W. Pankhurst and Ian S McLennan},
  journal={American journal of physiology. Endocrinology and metabolism},
  year={2013},
  volume={305 10},
  pages={
          E1241-7
        }
}
  • M. Pankhurst, I. McLennan
  • Published 15 November 2013
  • Chemistry, Medicine
  • American journal of physiology. Endocrinology and metabolism
Anti-Müllerian hormone (AMH) in blood is a marker of ovarian status in women and the presence of cryptic testes in babies. Despite this, the molecular form of AMH in blood has not been verified. AMH is synthesized as an inert proprotein precursor (proAMH), which can be cleaved to yield NH2-terminal (AMHN) and COOH-terminal (AMHC) fragments, that can complex noncovalently (AMHN,C). Developing males have 10-fold more AMH than young adults. We report here that human blood is a mixture of inactive… 
The Anti-Müllerian Hormone Precursor (proAMH) Is Not Converted to the Receptor-Competent Form (AMHN,C) in the Circulating Blood of Mice.
TLDR
The data suggest that the ratio of proAMH to AMHN,C in the circulation is not altered after it is released from the gonads and that the levels of these 2 circulating forms are likely to reflect AMH activity in the gonad.
Most Cleaved Anti-Müllerian Hormone Binds Its Receptor in Human Follicular Fluid but Little Is Competent in Serum.
TLDR
The results support an autocrine role for AMH in the pathophysiology of PCOS in the follicle and indicate that AMH undergoes interactions or structural changes after cleavage that prevent receptor binding, meaning, unexpectedly, that the level of cleavage in biological fluids does not always reflect thelevel of bioactive AMH.
Relative levels of the proprotein and cleavage‐activated form of circulating human anti‐Müllerian hormone are sexually dimorphic and variable during the life cycle
TLDR
The cleavage of circulating AMH varies extensively within the human population, with most individuals having significant levels of proAMH.
Anti-Müllerian hormone is a gonadal cytokine with two circulating forms and cryptic actions.
TLDR
Anti-Müllerian hormone is male specific during the initial stage of development, and theoretically should produce male biases throughout the body by adding a male-specific amplification of BMP/GDF signalling.
High Variability of Molecular Isoforms of AMH in Follicular Fluid and Granulosa Cells From Human Small Antral Follicles
TLDR
This study detected several AMH forms in FF and GCs obtained from human small antral follicles, which suggests that intrafollicular processing of AMH is complex and variable, and it may be difficult to develop an antibody-based AMH assay that detects all AMH isoforms.
Conserved Anti-Müllerian Hormone: Anti-Müllerian Hormone Type-2 Receptor Specific Interaction and Intracellular Signaling in Teleosts1
TLDR
Cl cloning sea bass amhr2, the production of a recombinant sea bass Amh, and the functional analysis of this ligand-receptor couple revealed that sea bassamhr2 segregates with Amhr2 from other vertebrates, and revealed that this piscine receptor is capable of activating Smad proteins.
Proteolytic processing of anti-Müllerian hormone differs between human fetal testes and adult ovaries.
TLDR
The present findings suggest that processing of AMH is a tightly regulated process, which is likely to be important for the function of AMh and which differs between the two sexes.
Development of a recombinant CHO cell line Anti-Müllerian Hormone
Anti-Müllerian hormone (AMH) is biological marker for the ovarian reserve, independent of the menstrual cycle. The AMH serum level can be measured with immunoassay in order to predict premature
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.
TLDR
Anti-Müllerian hormone (AMH) exemplifies a new mechanism for receptor engagement in which interaction with the type II receptor promotes pro-region dissociation to generate mature ligand.
Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years.
TLDR
Findings include detectable AMH serum levels at all ages, with the highest measured levels during infancy, and at the time of puberty, AMH concentrations declined and remained relatively stable throughout adulthood.
Biosynthesis of labelled anti-müllerian hormone by fetal testes: Evidence for the glycoprotein nature of the hormone and for its disulfide-bonded structure
The role of anti-Müllerian hormone (AMH) during follicle development in a monovulatory species (sheep).
TLDR
The results indicate that AMH does not affect the rate of primordial follicle recruitment but appears to regulate the rate at which follicles progress through the gonadotropin-responsive phase, during which it is maximally expressed.
Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease.
  • M. Nachtigal, H. Ingraham
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 1996
TLDR
The results suggest that MIS is a natural substrate for PC5, thereby supporting a role for prohormone convertases in the activation of transforming growth factor beta-related hormones during development.
Müllerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids.
TLDR
It is shown that both transcription and processing of MIS may be differentially modulated by gonadotropins and sex steroids, and human CG and testosterone do not affect transcription, but may regulate the cleavage and/or dissociation of MIS.
Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan.
TLDR
It is concluded that glycosylation of Asn(302) of the alpha-subunit of inhibin A and B results in a decrease in bioactivity, and the effect on inhibition A, at least, is explained by its reduced affinity to betaglycan.
Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
TLDR
Results indicate that the N-terminus of MIS, unlike that of the other members of the transforming growth factor-beta family, plays a role in maintaining the biological activity of the C-termini of MIS.
Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
TLDR
Since the purification protocol of MIS RR is less complicated than that for wild-type MIS, which requires subsequent enzymatic activation, MIS RR can be used for scale-up production with increased yields for further therapeutic trials against MIS-sensitive tumors.
...
1
2
3
4
...